Tomorrow's prenatal genetic testing. Should we test for 'minor' diseases?

Area of Science:

• Reproductive genetics
• Bioethics
• Medical ethics

Background:

• Advancements in genetic knowledge enable prenatal testing for diverse fetal genetic traits.
• This capability expands potential indications for selective abortion following prenatal diagnosis.

Purpose of the Study:

• To explore the ethical implications of expanding prenatal testing and selective abortion.
• To evaluate different ethical viewpoints on the scope of prenatal genetic testing.
• To propose a framework for future reproductive genetic counseling.

Main Methods:

• Analysis of ethical viewpoints on prenatal testing and selective abortion.
• Discussion of the distinction between disease and non-disease characteristics.
• Evaluation of the principle of nondirectiveness in genetic counseling.

Main Results:

• Prenatal testing may extend beyond severe diseases to mild, late-onset, treatable conditions, and even non-disease traits.
• Ethical debates exist regarding restricting testing to severe disorders versus honoring patient requests.
• Concerns arise regarding abortions for trivial reasons and potential societal impacts of non-disease trait selection.

Conclusions:

• The distinction between disease and non-disease characteristics provides a basis for future reproductive genetic testing and counseling.
• This approach aims to balance patient autonomy with ethical considerations and societal well-being.
• Future genetic counseling should navigate the complexities of expanding testing capabilities responsibly.